Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and ...